Aditxt, Inc. (ADTX) financial statements (2022 and earlier)

Company profile

Business Address 737 N. FIFTH STREET, SUITE 200
RICHMOND, VA 23219
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,8725,4698,61014,04510,50113,71650
Cash and cash equivalents7,8725,4698,61014,04510,50113,71650
Receivables5906,500     
Inventory, net of allowances, customer advances and progress billings495      
Inventory495      
Prepaid expense46041653238114823825
Intangible current assets    321  
Other undisclosed current assets  78438364324 
Total current assets:9,41712,3869,92714,80911,03314,27875
Noncurrent Assets
Operating lease, right-of-use asset    1,256  
Intangible assets, net (including goodwill)214241268295321  
Intangible assets, net (excluding goodwill)214241268295321  
Deposits noncurrent assets379316272727262 
Other noncurrent assets29042262    
Other undisclosed noncurrent assets6,3646,2225,3762,8414141,028543
Total noncurrent assets:7,2477,2015,9783,2082,0631,090543
TOTAL ASSETS:16,66419,58715,90518,01713,09715,368618
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,5761,6561,2129732424232,269
Other undisclosed accounts payable and accrued liabilities1,5761,6561,2129732424232,269
Debt      831
Deferred rent credit18618112310 3 
Due to related parties      10
Other liabilities    7  
Other undisclosed current liabilities1,8461,7643,8932,4219793311,221
Total current liabilities:3,6073,6015,2283,4051,2277564,330
Noncurrent Liabilities
Long-term debt and lease obligation    858865 
Operating lease, liability    858865 
Other undisclosed noncurrent liabilities2,8763,0144,7133,242(858)(865) 
Total noncurrent liabilities:2,8763,0144,7133,242 865 
Total liabilities:6,4836,6149,9416,6472,0851,6214,330
Stockholders' equity
Stockholders' equity attributable to parent10,18112,9725,96411,37011,01113,747(3,712)
Common stock4524151513124
Treasury stock, value(202)(202)(202)(202)(202)(202)(202)
Additional paid in capital77,69156,45039,58838,81632,07930,1359,939
Accumulated deficit(67,353)(43,300)(33,437)(27,259)(20,879)(16,198)(13,454)
Total stockholders' equity:10,18112,9725,96411,37011,01113,747(3,712)
TOTAL LIABILITIES AND EQUITY:16,66419,58715,90518,01713,09715,368618

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues105      
Cost of revenue
(Cost of Goods and Services Sold)
    (108)(44) 
Gross profit:    (108)(44) 
Operating expenses(24,021)(6,073)(5,775)(6,093)(4,672)(2,745)(398)
Other undisclosed operating income27   10844 
Operating loss:(23,994)(6,073)(5,775)(6,093)(4,672)(2,745)(398)
Nonoperating income (expense)(59)(3,688)(403)(287)(9)0(136)
Investment income, nonoperating(40)430000 
Interest and debt expense (2,501)(20)(17)(10) (0)
Loss from continuing operations before equity method investments, income taxes:(24,053)(12,262)(6,198)(6,396)(4,691)(2,744)(535)
Other undisclosed income from continuing operations before income taxes 2,501201733 0
Loss from continuing operations before income taxes:(24,053)(9,761)(6,178)(6,380)(4,659)(2,744)(534)
Other undisclosed loss from continuing operations(100)      
Loss from continuing operations:(24,153)(9,761)(6,178)(6,380)(4,659)(2,744)(534)
Other undisclosed income before gain (loss) on sale of properties10,896      
Loss before gain (loss) on sale of properties:(13,256)(9,761)(6,178)(6,380)(4,659)(2,744)(534)
Other undisclosed net loss(10,796)   (206)  
Net loss:(24,053)(9,761)(6,178)(6,380)(4,865)(2,744)(534)
Other undisclosed net income attributable to parent    184  
Net loss attributable to parent:(24,053)(9,761)(6,178)(6,380)(4,681)(2,744)(534)
Other undisclosed net income available to common stockholders, basic24,093      
Net income (loss) available to common stockholders, diluted:41(9,761)(6,178)(6,380)(4,681)(2,744)(534)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(24,053)(9,761)(6,178)(6,380)(4,865)(2,744)(534)
Comprehensive loss, net of tax, attributable to parent:(24,053)(9,761)(6,178)(6,380)(4,865)(2,744)(534)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: